Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.

The Journal of reproductive medicine - 1 Feb 1998

Fulop V, Mok S C, Genest D R, Szigetvari I, Cseh I, Berkowitz R S

Abstract excerpt

OBJECTIVE: To determine the expression of bcl-2, c-myc, c-fms and c-erbB-2 oncoproteins in normal placentas, partial and complete hydatidiform moles, and choriocarcinomas and to examine the possible presence of mutations in the K-ras gene in complete moles and choriocarcinomas. STUDY DESIGN: The expression of the above oncoproteins was determined immunohistochemically by specific antibodies for these proteins on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Membrane
Share to Cytoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Immunohistochemistry

Share to Mutation

Share to Polymerase Chain Reaction

Share to Pregnancy

Share to Proto-Oncogene Proteins

Source

Identifiers

PMID: 9513871

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.PMID 9513871Read ↗

p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform molesSemantic proximity Read ↗

Discrimination of Complete Hydatidiform Mole From Its Mimics by Immunohistochemistry of the Paternally Imprinted Gene Product p57 KIP2Semantic proximity Read ↗

Expression of ZO-1 and occludin in normal human placenta and in hydatidiform molesSemantic proximity Read ↗

Expression of the Colony-Stimulating Factor-1 Receptor (c-fms Proto-Oncogene Product) in the Human Uterus and Placenta1Semantic proximity Read ↗

Induction of apoptosis in human choriocarcinoma cell lines by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone).Semantic proximity Read ↗

Molecular Basis of Hydatidiform Moles – A Systematic ReviewSemantic proximity Read ↗

Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole.Semantic proximity Read ↗

p57KIP2 immunohistochemical expression: a useful diagnostic tool in discrimination between complete hydatidiform mole and its mimicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.